The Lancet (2023) 3
Book a Consultation Meet with our medical provider for a comprehensive consultation where well review your health history, discuss your goals, and create a personalized treatment plan tailored to your body, lifestyle, and desired results
This is not a benign oral supplement: treat it with the same caution as any GH-elevating compound
"Finding new and better treatments is critically important to help people live healthier lives." References Nirupam M Srinivasan, Mehdi Farokhnia, Lisa A Farinelli, Anna Ferrulli, Lorenzo Leggio, GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer, Journal of the Endocrine Society , Volume 9, Issue 11, November 2025, bvaf141,
C.O'DonnellC
Site guidance follows the DailyMed pen label for this Phase 3 compound